NCT07242235

Brief Summary

Low back pain is frequently associated with increased tone and stiffness of the lumbar erector spinae muscles, which may contribute to pain and functional limitation. Transcutaneous electrical nerve stimulation (TENS) is a non-invasive, safe, and widely used modality for pain reduction, but its very short-term (immediate) effects on lumbar muscle stiffness have not been clearly demonstrated. This randomized controlled trial will compare a single 20-minute session of conventional TENS with a control/rest condition in patients with non-specific low back pain. The primary outcomes will be change in lumbar erector spinae muscle stiffness (Myoton) and change in pain intensity (VAS) from baseline to immediately after the intervention. We hypothesize that TENS will produce a greater immediate reduction in muscle stiffness and pain than control.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 21, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

November 25, 2025

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

5 days

First QC Date

November 17, 2025

Last Update Submit

November 17, 2025

Conditions

Keywords

TENSLow Back PainMuscle StiffnessRandomized Controlled Trial

Outcome Measures

Primary Outcomes (2)

  • Change in lumbar erector spinae muscle stiffness

    Muscle stiffness of the lumbar erector spinae will be measured with a handheld myotonometer (e.g. Myoton) at standardized lumbar levels. The outcome is the change score (post - pre) between TENS and control groups. Lower values indicate reduced stiffness.

    Baseline (pre-intervention) and immediately post-intervention (within ~5 minutes of completing the 20-minute session)

  • Change in pain intensity (VAS)

    Pain intensity will be assessed using a 10-cm Visual Analog Scale (0 = no pain, 10 = worst pain). The outcome is the change score (post - pre) to compare TENS and control groups. Lower scores indicate pain reduction.

    Baseline (pre-intervention) and immediately post-intervention (within ~5 minutes of completing the 20-minute session)

Study Arms (2)

Experimental: TENS

EXPERIMENTAL

Participants receive a single 30-minute session of conventional TENS applied bilaterally over the lumbar paraspinal (erector spinae) region. Pre- and post-intervention Myoton and VAS measurements are taken.

Device: Transcutaneous Electrical Nerve Stimulation (TENS)

Control: Rest/Positioning

OTHER

Participants are positioned in the same way and remain at rest for 20 minutes without active TENS. Pre- and post-intervention Myoton and VAS measurements are taken.

Device: Transcutaneous Electrical Nerve Stimulation (TENS)

Interventions

Conventional TENS; frequency 80-100 Hz, pulse width 100-150 μs, intensity adjusted to strong but comfortable sensory level without muscle contraction; total duration 20 minutes; electrodes placed bilaterally at lumbar erector spinae level.

Also known as: Rest/Observation
Control: Rest/PositioningExperimental: TENS

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-30 years
  • Non-specific low back pain persisting or recurring for ≥3 months
  • Reported tenderness/stiffness on palpation of the lumbar erector spinae muscles
  • Able to understand the study procedures and provide written informed consent
  • Able to attend on the same day for TENS application and pre-/post-intervention measurements

You may not qualify if:

  • Low back pain with a specific cause (e.g. lumbar disc herniation with radiculopathy, infection, tumor, fracture, severe deformity)
  • Open wound, dermatitis, or any skin condition in the lumbar area that prevents electrode placement
  • Presence of a cardiac pacemaker or other implanted electronic device
  • Electrotherapy, injection, or manual therapy applied to the lumbar region within the previous 48 hours
  • Pregnancy
  • Severe neurological deficit or sensory loss
  • Use of analgesics/NSAIDs at a level that may interfere with pain or stiffness assessment at the time of evaluation
  • Any other condition deemed unsafe or inappropriate by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erzurum Technical University

Erzurum, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Low Back Pain

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Gökhan YAĞIZ, Dr.

    Amasya University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Esedullah AKARAS, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessor who performs Myoton and VAS measurements will be blinded to group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized (1:1) to active TENS or control/rest; both groups are assessed pre- and immediately post-intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

November 17, 2025

First Posted

November 21, 2025

Study Start

November 25, 2025

Primary Completion

November 30, 2025

Study Completion

December 1, 2025

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the study is small, single-center, and includes identifiable clinical measurements that could risk participant privacy despite de-identification.

Locations